Insight Molecular Diagnostics Inc. (IMDX) insider trading.
In Q3 2026, insiders at Insight Molecular Diagnostics Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-07-06
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Arno Andrew | Director | 1 | 0 | 0 |
| Last Andrew J. | Director | 1 | 0 | 0 |
| Silverman Lou | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Arno Andrew | F (D) | 12,100 | $5.69 | 156,785 | Form 4 |
| 2026-07-01 | Last Andrew J. | F (D) | 7,700 | $5.69 | 58,752 | Form 4 |
| 2026-07-01 | Silverman Lou | F (D) | 7,700 | $5.69 | 55,807 | Form 4 |
Transaction codes in this quarter
Get IMDX insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1642380&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · IMDX company page · Insight Molecular Diagnostics Inc. on SEC.gov
Questions
Are insiders buying or selling Insight Molecular Diagnostics Inc. (IMDX)?
In Q3 2026, insiders at Insight Molecular Diagnostics Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Insight Molecular Diagnostics Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/imdx.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.